Shots:
- 23andMe signs a SPAC merger with VGAC for an enterprise value of ~$3.5B, including $509M in cash in trust account and $250M PIPE of common stock at $10.00/share
- If no public shareholders of VGAC exercise their redemption rights, 23andMe will be capitalized up to $984M in cash to fund operations & support growth initiatives. The transaction is expected to be close in Q2’21
- 23and Me will be the 100% equity holder into the combined company while the new company will trade under the ticker “ME”. Current shareholders of 23andMe will own 81% of the combined company
Click here to read full press release/ article | Ref: 23andMe | Image: Wikipedia
The post 23andMe Going Public Via Virgin Group SPAC Merger first appeared on PharmaShots.
